Skip to primary navigation Skip to main content
0 item $0.00

Atherothrombosis and Vascular Biology

Read more

Laboratory head

i Profile of author

Latest Achievements

RT Hall Prize for outstanding achievements in cardiovascular research (2014)

Ross Hohnen Award for the best research application, National Heart Foundation (2012)

World Congress of Cardiology Fellowship Award, National Heart Foundation of Australia (2005)

Schwarz-Monheim-Prize of the German Society of Angiology (2000)

Principal Research Fellow, National Health and Medical Research Council of Australia (2014)

Read full biography
Professor Karlheinz Peter NHMRC Principal Research Fellow
Developing advanced biotechnological tools for molecular imaging and innovative therapy of atherosclerosis, thrombosis and inflammation.


Scientific staff

Dr Sara Baratchi Dr Laura Bienvenu Ms Viktoria Rose Bongcaron Dr Yung-Chih (Ben) Chen Ms Eleanor Eddy Dr Hamid Hosseini Ms Ana Maluenda Dr James McFadyen Dr Jonathan Noonan Dr Xiaowei Wang Ms May Lin Yap Dr Kristina Zaldivia


Ms Varni Doma Dr Alex Huang Ms Julia Loseff-Silver Dr Jath Palasubramaniam Ms Amy Kate Searle Mr Aidan Walsh Dr Abbey Willcox Ms Ya-Lan (Alice) Ying Ms EeFang Yu

Consulting scientist

Professor Geoff Pietersz


About the Atherothrombosis and Vascular Biology laboratory

The Atherothrombosis and Vascular Biology laboratory pursues a broad range of projects that have the common focus on improving diagnosis and therapy of thrombotic and inflammatory diseases such as myocardial infarction and atherosclerosis. A range of biotechnological methods are used, including recombinant protein design/production, generation of functionalised nanoparticles/ lipsomes/microbubbles, cell culture, flow cytometry, flow chamber, intravital microscopy, ultrasound, MRI, PET various fluorescence imaging systems and various animal models of thrombosis, atherosclerosis and inflammation. All of these projects have a strong translational orientation, which is facilitated by several laboratory members (physicians/cardiologists) treating patients with cardiovascular diseases. Several of the research projects resulted in patents that are currently being further developed to ultimately improve the health of patients.

Work in the laboratory is particularly attractive for students/postdoctoral researchers who are interested in the development of advanced biotechnological tools for molecular imaging and novel therapeutics (e.g. regenerative stem cell therapy and microRNA for plaque stabilisation). The translational direction of the laboratory and the inclusion of patients in studies, such as the identification of vulnerable, rupture-prone atherosclerotic plaques, is highly attractive for physician scientists.

Research focus

  • Molecular imaging of thrombosis and inflammation using MRI, PET, ultrasound, FLECT, IVIS.
  • Novel recombinant therapeutics for thrombotic and inflammatory diseases.
  • Microfluidic flow chambers.
  • Intravital microscopy.
  • Flow cytometry.
  • Animal models of thrombosis and inflammation.
  • Production of recombinant proteins for diagnosis and therapy.
  • Diagnosis and treatment of patients with coronary artery disease and myocardial infarction.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more